A clinical study of LCOX to check its efficacy and tolerability in osteoarthritis patients of Knee.
Phase 2
- Conditions
- Health Condition 1: null- osteoarthritis of knee joints
- Registration Number
- CTRI/2015/06/005864
- Lead Sponsor
- Pharmanza Herbal Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
a. Clinico-radiologically diagnosed patients of OA
knee
b. Patients willing to participate and give signed
informed consent
c. Either gender
d. Age >40 years
Exclusion Criteria
a. History of peptic ulcer, acid peptic disease or
any other concurrent illness
b. End organ damage. RFT, LFT will be conducted
pre and post session.
d. Chronic smoker/ alcoholic
e. History of allergy against herbal products or
NSAIDs
f. Subjects who cannot be relied upon to comply
with instructions
g. Pregnant or breast feeding women
h. Gouty Arthritis, Rheumatoid Arthritis,
Psoriatic
arthritis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method difference between WOMAC score in two groups <br/ ><br>Timepoint: at baseline after one month after second month
- Secondary Outcome Measures
Name Time Method decrease in level of CTX2 in urine samples of two groups.Timepoint: at baseline and after second month